NCT07373197 is a NA clinical trial of Muscle strangulation in Strabismus, Divergent, sponsored by Sohag University.

Who is sponsoring NCT07373197?

NCT07373197 is sponsored by Sohag University.

What drugs are being tested in NCT07373197?

Interventions in NCT07373197: Muscle strangulation.

What condition does NCT07373197 study?

NCT07373197 studies Strabismus, Divergent.

Is NCT07373197 still recruiting?

NCT07373197 is currently completed. Last updated 28 January 2026.

Last reviewed 2026-01-28 · How we verify

NCT07373197

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lateral Rectus Muscle Strangulation in Cases of Exotropia

Completed NA Last updated 28 January 2026

What this trial tests

NA trial testing Muscle strangulation in Strabismus, Divergent in 12 participants. Completed in 2 February 2025.

Timeline

1 January 2024

Primary endpoint
1 July 2024

2 February 2025

Quick facts

Lead sponsor	Sohag University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	12
Start date	1 January 2024
Primary completion	1 July 2024
Estimated completion	2 February 2025
Sites	1 location across Egypt

Drugs / interventions tested

Muscle strangulation

Conditions studied

Strabismus, Divergent — all drugs for Strabismus, Divergent →

Sponsor

Sohag University

Who can join

Adults 15 to 50, any sex, with Strabismus, Divergent. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of our study to evaluate effect of lateral rectus muscle strangulation as a novel effective weakening technique in cases of exotropia. It is a case-series intervensional study with a total 12 participant who are diagnosed as exophoria or intermittent exotropia who are older than 4 years old. All patients will be assessed regarding their angle of deviation and then undergo lateral rectus muscle strangulation under general anesthesia and then will be followed- up at 1st day, 1st week, 1st month and 6th months.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Sohag University trials

Trials by the same sponsor.

NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07373197 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sohag University
Last refreshed: 28 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07373197.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing